Friday, 14 December 2018

Heart Disease Biomarkers and Screening Tests

Cardiovascular or cardiac diseases are the leading cause of death worldwide, as mortality rates increase steadily due to the aging of the population. As such, it is important for key players in the field of medicine to detect the early symptoms of such conditions and to provide an empirical profile of biomarkers of heart disease.

Heart Disease Biomarkers

Biomarkers are present in many types of diseases, and their identification is an important aspect of health management since it facilitates the early detection of a certain disease and the prevention of a full-blown medical condition. Among heart conditions, biomarkers could be divided into several categories due to a large number of diseases associated with the disease. However, researchers have discovered that in many heart conditions, blood pressure and cholesterol levels are often real risk factors.

Screening Tests for Heart Diseases

Even with the presence of modern medical technologies, the process of detecting heart disease remains a challenge. However, the advent of biomarker research in cardiovascular diseases has been a great leap in the characterization and development of new techniques for detecting heart disease.

Screening Tests for Heart Disease Diagnosis

Doctors notice key symptoms in the diagnosis of certain heart conditions; however, a confirmatory test would always be recommended to ensure the correct diagnosis and appropriate treatment strategies. Several screening tests are available for the diagnosis of heart disease.
Electrocardiogram (EGC) -a device that uses electrical signals to observe heart rhythm and structure
Echocardiogram: a non-invasive technique that performs ultrasound in the chest area
Cardiac computed tomography (CT) scan: a collection of images around the heart to provide a complete cardiac figure
Cardiac magnetic resonance imaging (MRI): similar to computed tomography, an image of the heart is acquired for evaluation.

Key screening tests for the monitoring of heart disease

The treatment for a certain heart disease does not stop after the operation or medication. 
As part of cardiovascular management, doctors will always want to monitor heart condition after treatment. These are facilitated by a series of methods by measuring the levels of blood pressure, cholesterol, body weight, blood glucose levels and introducing physical activity or diet.

Grace your valuable presence at International Conference on Biomarkers and Clinical Research during January 30-31, 2019 in Abu Dhabi, UAE for more recent updates in Biomarkers and Clinical Research.

No comments:

Post a Comment